Toshitaka Nakamura
Publications by Year
Research Areas
Bone health and osteoporosis research, Bone health and treatments, Bone Metabolism and Diseases, Bone and Joint Diseases, Hip and Femur Fractures
Most-Cited Works
- → Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation(2000)472 cited
- → Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary(2012)355 cited
- → Holocene East Asian monsoonal precipitation pattern revealed by grain-size distribution of core sediments of Daihai Lake in Inner Mongolia of north-central China(2005)352 cited
- → Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk(2012)258 cited
- → Effects of 1?-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis(1994)224 cited
- → Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)(2008)185 cited
- → A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures — A randomized, active comparator, double-blind study(2011)180 cited
- → Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study(2019)166 cited
- → Clinical Trials Express:Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)(2014)165 cited
- → Intravenous Pamidronate Prevents Femoral Bone Loss and Renal Stone Formation During 90-Day Bed Rest(2004)161 cited